| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
3,615 |
3,280 |
$785K |
| J2357 |
Injection, omalizumab, 5 mg |
484 |
321 |
$737K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
2,657 |
1,903 |
$679K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,941 |
10,466 |
$633K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,507 |
1,438 |
$189K |
| 95117 |
|
21,101 |
11,852 |
$189K |
| 96401 |
|
973 |
695 |
$103K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
583 |
523 |
$45K |
| 95115 |
|
4,907 |
2,784 |
$36K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
746 |
717 |
$30K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
337 |
303 |
$17K |
| 94060 |
|
409 |
405 |
$15K |
| 94729 |
|
292 |
288 |
$13K |
| 94726 |
|
293 |
289 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
132 |
100 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
545 |
347 |
$6K |
| 99215 |
Prolong outpt/office vis |
67 |
65 |
$6K |
| 99243 |
|
27 |
27 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
42 |
25 |
$557.93 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30 |
27 |
$405.16 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$36.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
12 |
$15.79 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,080 |
3,577 |
$1.58 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,015 |
900 |
$0.53 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
1,864 |
1,678 |
$0.01 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
760 |
706 |
$0.01 |
| G8482 |
Influenza immunization administered or previously received |
863 |
749 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
1,156 |
1,052 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
1,511 |
1,352 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
234 |
223 |
$0.00 |